ArticleFrontiers in immunology2025

Construction of a prognostic model based on palmitoylation-related lncRNAs for assessing drug benefits in breast cancer.

Yan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.